129 related articles for article (PubMed ID: 35878676)
1. The ERICH3 rs11580409 polymorphism is associated with 6-month antidepressant response in depressed patients.
Chappell K; Colle R; Ait Tayeb AEK; Bouligand J; El-Asmar K; Deflesselle E; Fève B; Becquemont L; Corruble E; Verstuyft C
Prog Neuropsychopharmacol Biol Psychiatry; 2022 Dec; 119():110608. PubMed ID: 35878676
[TBL] [Abstract][Full Text] [Related]
2. The
Chappell K; Colle R; Bouligand J; Trabado S; Fève B; Becquemont L; Corruble E; Verstuyft C
Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36613935
[TBL] [Abstract][Full Text] [Related]
3. The GG genotype of the serotonin 4 receptor genetic polymorphism, rs1345697, is associated with lower remission rates after antidepressant treatment: Findings from the METADAP cohort.
Poinsignon V; Colle R; Asmar KE; Mendez-David I; David DJ; Ait Tayeb AEK; Chappell K; Gressier F; Herrero H; Fève B; Becquemont L; Corruble E; Verstuyft C
J Affect Disord; 2022 Feb; 299():335-343. PubMed ID: 34906639
[TBL] [Abstract][Full Text] [Related]
4. TSPAN5, ERICH3 and selective serotonin reuptake inhibitors in major depressive disorder: pharmacometabolomics-informed pharmacogenomics.
Gupta M; Neavin D; Liu D; Biernacka J; Hall-Flavin D; Bobo WV; Frye MA; Skime M; Jenkins GD; Batzler A; Kalari K; Matson W; Bhasin SS; Zhu H; Mushiroda T; Nakamura Y; Kubo M; Wang L; Kaddurah-Daouk R; Weinshilboum RM
Mol Psychiatry; 2016 Dec; 21(12):1717-1725. PubMed ID: 26903268
[TBL] [Abstract][Full Text] [Related]
5. ERICH3: vesicular association and antidepressant treatment response.
Liu D; Zhuang Y; Zhang L; Gao H; Neavin D; Carrillo-Roa T; Wang Y; Yu J; Qin S; Kim DC; Liu E; Nguyen TTL; Biernacka JM; Kaddurah-Daouk R; Dunlop BW; Craighead WE; Mayberg HS; Binder EB; Frye MA; Wang L; Weinshilboum RM
Mol Psychiatry; 2021 Jun; 26(6):2415-2428. PubMed ID: 33230203
[TBL] [Abstract][Full Text] [Related]
6. SOD2 genetic polymorphism (rs4880) has no impact on 6-month response to antidepressant treatment and inflammatory biomarkers in depressed patients.
Ait Tayeb AEK; Becquemont L; El-Asmar K; Mahmoudi K; Colle R; Trabado S; Gressier F; Feve B; Corruble E; Verstuyft C
Basic Clin Pharmacol Toxicol; 2020 Mar; 126(3):289-295. PubMed ID: 31904901
[TBL] [Abstract][Full Text] [Related]
7. A 40-basepair VNTR polymorphism in the dopamine transporter (DAT1) gene and the rapid response to antidepressant treatment.
Kirchheiner J; Nickchen K; Sasse J; Bauer M; Roots I; Brockmöller J
Pharmacogenomics J; 2007 Feb; 7(1):48-55. PubMed ID: 16702979
[TBL] [Abstract][Full Text] [Related]
8. Association between serotonin transporter-linked polymorphic region and escitalopram antidepressant treatment response in Korean patients with major depressive disorder.
Won ES; Chang HS; Lee HY; Ham BJ; Lee MS
Neuropsychobiology; 2012; 66(4):221-9. PubMed ID: 23095326
[TBL] [Abstract][Full Text] [Related]
9. Effects of the serotonin transporter gene promoter polymorphism on mirtazapine and paroxetine efficacy and adverse events in geriatric major depression.
Murphy GM; Hollander SB; Rodrigues HE; Kremer C; Schatzberg AF
Arch Gen Psychiatry; 2004 Nov; 61(11):1163-9. PubMed ID: 15520364
[TBL] [Abstract][Full Text] [Related]
10. Genetic predictors of response to serotonergic and noradrenergic antidepressants in major depressive disorder: a genome-wide analysis of individual-level data and a meta-analysis.
Tansey KE; Guipponi M; Perroud N; Bondolfi G; Domenici E; Evans D; Hall SK; Hauser J; Henigsberg N; Hu X; Jerman B; Maier W; Mors O; O'Donovan M; Peters TJ; Placentino A; Rietschel M; Souery D; Aitchison KJ; Craig I; Farmer A; Wendland JR; Malafosse A; Holmans P; Lewis G; Lewis CM; Stensbøl TB; Kapur S; McGuffin P; Uher R
PLoS Med; 2012; 9(10):e1001326. PubMed ID: 23091423
[TBL] [Abstract][Full Text] [Related]
11. [Use of antidepressant drugs in schizophrenic patients with depression].
Micallef J; Fakra E; Blin O
Encephale; 2006; 32(2 Pt 1):263-9. PubMed ID: 16910628
[TBL] [Abstract][Full Text] [Related]
12. The serotonin transporter promoter polymorphism (5-HTTLPR) affects the relation between antidepressant serum concentrations and effectiveness in major depression.
Dreimüller N; Tadić A; Dragicevic A; Boland K; Bondy B; Lieb K; Laux G; Maier W; Müller MJ; Rao ML; Rietschel M; Röschke J; Zill P; Hiemke C
Pharmacopsychiatry; 2012 May; 45(3):108-13. PubMed ID: 22086748
[TBL] [Abstract][Full Text] [Related]
13. Serotonin receptor 2A gene polymorphism (-1438A/G) and short-term treatment response to citalopram.
Choi MJ; Kang RH; Ham BJ; Jeong HY; Lee MS
Neuropsychobiology; 2005; 52(3):155-62. PubMed ID: 16127283
[TBL] [Abstract][Full Text] [Related]
14. Role of the serotonin transporter gene locus in the response to SSRI treatment of major depressive disorder in late life.
Seripa D; Pilotto A; Paroni G; Fontana A; D'Onofrio G; Gravina C; Urbano M; Cascavilla L; Paris F; Panza F; Padovani A; Pilotto A
J Psychopharmacol; 2015 May; 29(5):623-33. PubMed ID: 25827644
[TBL] [Abstract][Full Text] [Related]
15. Is 5-HTTLPR linked to the response of selective serotonin reuptake inhibitors in MDD?
Illi A; Poutanen O; Setälä-Soikkeli E; Kampman O; Viikki M; Huhtala H; Mononen N; Haraldsson S; Koivisto PA; Leinonen E; Lehtimäki T
Eur Arch Psychiatry Clin Neurosci; 2011 Mar; 261(2):95-102. PubMed ID: 20640435
[TBL] [Abstract][Full Text] [Related]
16. Response to sertraline is influenced by GNβ3 gene G-350A variant in patients with major depressive disorder.
Firouzabadi D; Firouzabadi N; Kalani K; Zomorrodian K; Tehrani ES
Eur J Clin Pharmacol; 2019 Feb; 75(2):189-194. PubMed ID: 30324302
[TBL] [Abstract][Full Text] [Related]
17. Clinical outcomes and genome-wide association for a brain methylation site in an antidepressant pharmacogenetics study in Mexican Americans.
Wong ML; Dong C; Flores DL; Ehrhart-Bornstein M; Bornstein S; Arcos-Burgos M; Licinio J
Am J Psychiatry; 2014 Dec; 171(12):1297-309. PubMed ID: 25220861
[TBL] [Abstract][Full Text] [Related]
18. Monoamine transporter gene polymorphisms and antidepressant response in koreans with late-life depression.
Kim H; Lim SW; Kim S; Kim JW; Chang YH; Carroll BJ; Kim DK
JAMA; 2006 Oct; 296(13):1609-18. PubMed ID: 17018806
[TBL] [Abstract][Full Text] [Related]
19. The association of
Chappell K; Ait Tayeb AEK; Colle R; Bouligand J; El-Asmar K; Gressier F; Trabado S; David DJ; Feve B; Becquemont L; Corruble E; Verstuyft C
Front Pharmacol; 2022; 13():974570. PubMed ID: 36386175
[No Abstract] [Full Text] [Related]
20. 5-HT2A receptor -1438 G/A polymorphism and serotonergic antidepressant-induced sexual dysfunction in male patients with major depressive disorder: a prospective exploratory study.
Liang CS; Ho PS; Chiang KT; Su HC
J Sex Med; 2012 Aug; 9(8):2009-16. PubMed ID: 22612784
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
